Carcinoma of the prostate. Objective criteria of response.
Only 10% of patients with metastatic carcinoma of the prostate have measurable marker lesions. The lack of measurable tumor and biochemical markers in this disease makes the design of clinical trials of treatment and the interpretation of the results of these trials very difficult.